Investigation Report on China Glucosamine Market, 2010-2019
Description
Osteoarthritis (OA) is a kind of chronic degenerative disease, and it is also the commonest arthritis in the clinic. The lesion is a slow yet progressing process. Major symptoms include wearing away and damage of articular cartilage, whereas clinical symptoms include arthralgia, swelling of joint, joint deformity and limited mobility. The elderly are at high risk of osteoarthritis. About 70-90% of old people aged above 75 suffer from osteoarthritis. Common therapeutic medicines used for the treatment of osteoarthritis include analgesic and non-steroidal anti-inflammatory drugs (NSAID) which howeverwill initiate serious adverse reactions in gastrointestinal tract and cardiovascular system, particularly during long-term use. The optimal therapeutic medicine is disease modifying antirheumatic drug (DMARD) that can both alleviate arthralgia and delay the damaging process of joint structure. In the past ten years, chondroitin, an ingredient of cartilage, and glucosamine have been increasingly put into use around the world.
As a kind of natural monosaccharide, glucosamine is an ingredient of cartilage matrix and bone fluid. Glucosamine can complement ectogenous glucosaminoglycan, provide the precursor of disaccharide unit needed in the synthsis of glycosaminoglycan inside the body, and stimulate synthesis of proteoglycan and collagen in the chondrocyte, as well as complement lost ingredients of cartilage matrix and inhibit the expression of matrix metalloproteinase so as to maintain the normal metabolism of cartilage matrix and accelerate the recovery of cartilage. Besides, glucosamine can alleviate damage to cartilage by removing free radical and give play to the anti-flammable effect. Currently, glucosamine is still the most popular nutrition drug for joints and cartilages in the U.S. In Europe, it is managed as a prescription drug.
Glucosamine has been growing at a rapid pace after entering the Chinese market, with its annual sales value rising from CNY 42 million in 2005 to CNY 400 million in 2014 and its CAGR during the period of 2005-2014 reaching up to 28.46%. Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd and Jiangsu Qing Jiang Pharmaceutical Co., Ltd, among which Shanxi Zhongyuanwei Pharmaceutical Co., Ltd owns the largest market share, with its market share for sales value in 2014 reaching 27.5%.
It is estimated that glucosamine market in China will keep expanding in the next few years.
Readers can have access to at least the following information from this report:
Osteoarthritis (OA) is a kind of chronic degenerative disease, and it is also the commonest arthritis in the clinic. The lesion is a slow yet progressing process. Major symptoms include wearing away and damage of articular cartilage, whereas clinical symptoms include arthralgia, swelling of joint, joint deformity and limited mobility. The elderly are at high risk of osteoarthritis. About 70-90% of old people aged above 75 suffer from osteoarthritis. Common therapeutic medicines used for the treatment of osteoarthritis include analgesic and non-steroidal anti-inflammatory drugs (NSAID) which howeverwill initiate serious adverse reactions in gastrointestinal tract and cardiovascular system, particularly during long-term use. The optimal therapeutic medicine is disease modifying antirheumatic drug (DMARD) that can both alleviate arthralgia and delay the damaging process of joint structure. In the past ten years, chondroitin, an ingredient of cartilage, and glucosamine have been increasingly put into use around the world.
As a kind of natural monosaccharide, glucosamine is an ingredient of cartilage matrix and bone fluid. Glucosamine can complement ectogenous glucosaminoglycan, provide the precursor of disaccharide unit needed in the synthsis of glycosaminoglycan inside the body, and stimulate synthesis of proteoglycan and collagen in the chondrocyte, as well as complement lost ingredients of cartilage matrix and inhibit the expression of matrix metalloproteinase so as to maintain the normal metabolism of cartilage matrix and accelerate the recovery of cartilage. Besides, glucosamine can alleviate damage to cartilage by removing free radical and give play to the anti-flammable effect. Currently, glucosamine is still the most popular nutrition drug for joints and cartilages in the U.S. In Europe, it is managed as a prescription drug.
Glucosamine has been growing at a rapid pace after entering the Chinese market, with its annual sales value rising from CNY 42 million in 2005 to CNY 400 million in 2014 and its CAGR during the period of 2005-2014 reaching up to 28.46%. Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd and Jiangsu Qing Jiang Pharmaceutical Co., Ltd, among which Shanxi Zhongyuanwei Pharmaceutical Co., Ltd owns the largest market share, with its market share for sales value in 2014 reaching 27.5%.
It is estimated that glucosamine market in China will keep expanding in the next few years.
Readers can have access to at least the following information from this report:
- market size of glucosamine in China
- competitive landscape of glucosamine in Chinese market
- prices of glucosamine produced by different enterprises in China
- market outlook of glucosamine in China
- manufacturers of bone and muscle medication
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
SELECTED CHARTS
Chart Patent Status of Glucosamine in China
Chart Approval Information of Glucosamine in China
Chart Sales Status of Glucosamine in Chinese Market
Chart Sales Value of Glucosamine in China, 2010-2014
Chart Sales Value of Glucosamine in Some Regions of China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Glucosamine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Hisun Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Rottapharm Ltd (Ireland) in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Bright Future Pharmaceutical Laboratories Limited in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Tablets in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Capsules in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Granules (Oral Mediaction) in China, 2010-2014
Chart Price of Glucosamine Produced by Nanjing Hicin Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Sichuan Bao Guang Pharmaceutical Industry Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Jiangsu Qing Jiang Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Zhejiang Hisun Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Rottapharm Ltd (Italy) in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Rottapharm Ltd (Ireland) in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Bright Future Pharmaceutical Laboratories Limited in Some Cities of China in 2014
Chart Patent Status of Glucosamine in China
Chart Approval Information of Glucosamine in China
Chart Sales Status of Glucosamine in Chinese Market
Chart Sales Value of Glucosamine in China, 2010-2014
Chart Sales Value of Glucosamine in Some Regions of China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Glucosamine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Hisun Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Rottapharm Ltd (Ireland) in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Produced by Bright Future Pharmaceutical Laboratories Limited in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Tablets in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Capsules in China, 2010-2014
Chart Sales Value and Market Share of Glucosamine Granules (Oral Mediaction) in China, 2010-2014
Chart Price of Glucosamine Produced by Nanjing Hicin Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Sichuan Bao Guang Pharmaceutical Industry Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Jiangsu Qing Jiang Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Zhejiang Hisun Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Rottapharm Ltd (Italy) in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Rottapharm Ltd (Ireland) in Some Cities of China in 2014
Chart Price of Glucosamine Produced by Bright Future Pharmaceutical Laboratories Limited in Some Cities of China in 2014
